Navigation Links

Biology Technology

Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com

8/30/2014
Dallas, TX (PRWEB) August 31, 2014 The Global and China Electrical Insulating Varnish Industry is a professional and in-depth study on the current state of the Electrical Insulating Varnish industry in Global and China. The report provides a basic overview of the industry, including definitions, applications and industry chain structure. Global market analysis and Chinese domestic market... [Comments]

Pfenex Reports Second Quarter 2014 Results and Provides Business Update

8/29/2014
SAN DIEGO, Aug. 29, 2014  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014. "With the successful completion of our initial public offer... [Comments]

Breakthrough in light sources for new quantum technology

8/29/2014
Electronic circuits are based on electrons, but one of the most promising technologies for future quantum circuits are photonic circuits, i.e. circuits based on light (photons) instead of electrons. First, it is necessary to be able to create a stream of single photons and control their direc... [Comments]Breakthrough in light sources for new quantum technology

Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research

8/29/2014
Albany, New York (PRWEB) August 29, 2014 The global companion diagnostics market will be valued at $5.6 billion in 2019. It is expected to grow at a CAGR of 18.1% from 2013 to 2019, and was valued at $1.8 billion in 2013, according to a research report published by Transparency Market Research. For more information regarding analysis details and ToC, please visit: http://www.transparenc... [Comments]

Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research

8/29/2014
Albany, New York (PRWEB) August 29, 2014 According to a new market report published by Transparency Market Research “Global Orthobiologics Market” the global orthobiologics market was valued at USD 3,754.6 million in 2012 and is estimated to reach a market worth USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 to 2019. Nearly half of the population aged 50 years and above is afflict... [Comments]

Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald

8/29/2014
Pittsburgh, PA (PRWEB) August 29, 2014 Pittcon is pleased to announce that the 2015 Program Chairman, Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have organized a session on nanotechnology for presentation at JASIS on September 5, 2014. JASIS , Asia’s largest analytical and scientific instruments show, will be held September 3-5, 2014, in Makuhari Messe, Japan. Th... [Comments]

iCo Therapeutics Announces Second Quarter 2014 Financial Results

8/29/2014
VANCOUVER , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). Second Quarter 2014 Highlights Announced top-line results r... [Comments]

Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis

8/29/2014
Burnt Hills, NY (PRWEB) August 29, 2014 Local veterinarian, Dr. Keith Clement, and his team at Burnt Hills Veterinary Hospital are seeking candidates to participate in an investigational study of donor stem cells for dogs with osteoarthritis. The ultimate goal of this study is to determine if a single injection of donor stem cells into one or two arthritically affected joints can help redu... [Comments]

Livermore Team Awarded for Hydrogen Production Research

8/29/2014
Livermore, California (PRWEB) August 29, 2014 Three Lawrence Livermore researchers have received the Department of Energy's 2014 Hydrogen Production R&D Award for their research in producing hydrogen photoelectrochemically -- by splitting water using sunlight. Shared with collaborators from the National Renewable Energy Laboratory (NREL) and the University of Nevada, Las Vegas... [Comments]

The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies

8/29/2014
Boston, MA (PRWEB) August 29, 2014 Due to a misstatement posted by the Family Resource Council (FRC) last week, the Adult Stem Cell Technology Center, LLC ( ASCTC ) was reported as an entity accepting donations to support stem cell therapy research that might benefit ALS patients. Because of ASCTC's exclusive focus on developing adult stem cells for new stem cell technologies and the... [Comments]

The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End

8/29/2014
Boston, MA (PRWEB) August 29, 2014 A major challenge before new biotechnology start-up companies, especially ones in the biotech start-up dense realm of Boston-Cambridge, is gaining visibility that can lead to important strategic alliances and able investors. James Sherley, the Director of Boston’s Adult Stem Cell Technology Center, LLC (ASCTC), has made increasing the local and national vi... [Comments]

Medicine Technology

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

8/30/2014
MARLBOROUGH, Mass. , Aug. 30, 2014  Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure patients.  Faiez Zannad, M.D., Ph.D., Professor of Thera... [Comments]

Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014

8/30/2014
ANDOVER, Mass. , Aug. 30, 2014   Royal Philips  (NYSE: PHG, AEX: PHIA) today announced the launch of Affiniti, a new ultrasound system designed to enable global hospitals and health systems to overcome the demands of increasing patient volumes and cost pressures. Making its debut at the  European Society of Cardiology (ESC) Congress 2014 in Barcelona... [Comments]

X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019

8/29/2014
DALLAS , Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report on Global and Chinese X-Ray Crystallography Scanner Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese X-Ray Crystallography Scanner industry . The report firstly reviews the basic information of X-Ray Crystallography Scanner including its classification, application and manufacturing tec... [Comments]

CannaMed Announces Name Change and Trading Symbol Change

8/29/2014
LOS ANGELES , Aug. 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), an entity providing both financing alternatives and turnkey support services for the lawfully organized cannabis industry, is pleased to announce that FINRA processed and approved the Company's name and symbol change request. Effective today, August 29, 2014, CannaMed Corporation will be known... [Comments]

Implementing a Strategic Thought Leader Management & Engagement System

8/29/2014
CHAPEL HILL, N.C. , Aug. 29, 2014 The clinical and medical insights provided by Key Opinion Leaders (KOLs) can be the difference between a product's success or failure. Despite this, many biopharmaceutical organizations struggle to effectively map and stratify KOL targets – and then to coordinate activities and outreach over time to build the type of strong relationships... [Comments]

Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector

8/29/2014
CHAPEL HILL, N.C. , Aug. 29, 2014 The Competitive Intelligence (CI) function is evolving in the face of regulatory and marketplace changes. CI leaders who adjust will succeed, and those who don't will flounder. In a new Best Practices, LLC study CI leaders from 32 biopharmaceutical organizations delivered a host of actionable insights, including: - Use secondary research... [Comments]

SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet.

8/29/2014
WILSONVILLE, Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  Photo - http://photos.prnewswire.com/prnh/20140828/141361 SAM Medical Products announced today that it has begun notifying customers of a voluntary recall to address a potential issue with a clip used to secu... [Comments]

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP

8/29/2014
NEW YORK , Aug. 29, 2014 Pomerantz LLP has filed a class action lawsuit against EDAP TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ) and certain of its officers.  The class action, filed in United States District Court, Southern District of New York , and docketed under 14-cv-6069, is on behalf of a class consisting of all persons or entities who purchased ED... [Comments]

Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents

8/29/2014
MARLBOROUGH, Mass. , Aug. 29, 2014  A Boston Scientific Corporation (NYSE: BSX ) prospective, multinational study on stent removability and preliminary long term stricture resolution of benign biliary strictures has been published in the August issue of the peer-reviewed journal, Gastroenterology. The multinational study 1 is being conducted in 11 countries and five... [Comments]

Mast Therapeutics Announces Management Change

8/29/2014
SAN DIEGO , Aug. 29, 2014   Mast Therapeutics, Inc. (NYSE MKT: MSTX), an emerging biopharmaceutical company, announced today that Santosh Vetticaden, Chief Medical Officer and Senior Vice President, will be leaving the Company, for personal reasons, in mid-September.  Edwin L. Parsley , D.O., the Chief Medical Officer of Aires Pharmaceuticals, which Mast acquired ea... [Comments]

Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer

8/29/2014
MENLO PARK, Calif. , Aug. 29, 2014 Medina Medical announced today that Mr. Engelson joined Medina Medical as CEO and member of the Board of Directors on August 18, 2014. Mr. Engelson brings three decades of medical device development and commercialization experience, including over a decade of direct experience in Medina Medical's field. Mr. Engelson previously served as a Par... [Comments]

(Date:8/30/2014)... (PRWEB) August 31, 2014 The ... a professional and in-depth study on the current ... Global and China. , The report provides a ... and industry chain structure. Global market analysis and ... focus on history, developments, trends and competitive landscape ...
(Date:8/29/2014)... 29, 2014  Pfenex Inc. (NYSE MKT: PFNX), ... of high-value and difficult to manufacture proteins including ... reported financial results for the second quarter ended ... completion of our initial public offering, we have ... product candidates, derived from our proprietary protein expression ...
(Date:8/29/2014)... but one of the most promising technologies for future ... light (photons) instead of electrons. First, it is necessary ... photons and control their direction. Researchers around the world ... control, but now scientists at the Niels Bohr Institute ... emitted one at a time and in a particular ...
(Date:8/29/2014)... York (PRWEB) August 29, 2014 ... at $5.6 billion in 2019. It is expected ... 2013 to 2019, and was valued at $1.8 ... published by Transparency Market Research. , For more ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled ...
Breaking Biology Technology:Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 2Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3
... Funding Milestone Continues Progress at Seneca, Illinois ... ... NBF ) announced today that it has satisfied the conditions ... million,senior secured credit facility with WestLB AG, one of the world,s ...
... Phase 2b Trial Expected to Begin in the ... 4 Mpex Pharmaceuticals, Inc. today,announced that the ... Products Development has granted Mpex orphan drug designation ... pulmonary,infections due to Pseudomonas aeruginosa and other bacteria ...
... the Chinese Pharmaceutical ... CHENGDU, China, March 4 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, ... and,supplier of modernized traditional Chinese medicine ("TCM") based ... members:,Professor Zunjian Zhang, Ph.D., Professor Jianping Hou, Ph.D. ...
Cached Biology Technology:Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility 2Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis 2Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis 3Tianyin Pharmaceutical Appoints Three New Independent Board Members 2Tianyin Pharmaceutical Appoints Three New Independent Board Members 3Tianyin Pharmaceutical Appoints Three New Independent Board Members 4
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3